Sanofi and Seagen announce collaboration to develop and commercialize multiple novel antibody-drug conjugates
- Details
- Category: Sanofi

Pfizer and BioNTech aubmit for U.S. Emergency Use Authorization of an additional booster dose of their COVID-19 vaccine for older adults
- Details
- Category: Pfizer

Pfizer updates company position in Russia
- Details
- Category: Pfizer

The international community has implemented unprecedented sanctions to Russia.
Novartis signs initial agreement with Carisma Therapeutics for the manufacturing of HER 2 targeted CAR-M cell therapy
- Details
- Category: Novartis

Under the terms of the initial agreement, the Carisma Therapeutics manufacturing process will be transferred to the Novartis Cell Therapy Site in Morris Plains, U.S, starting in the coming days.
Novartis, Voyager Therapeutics reach license option agreement for next-generation gene therapy vectors for neurological diseases
- Details
- Category: Novartis

Statement on humanitarian aid in Ukraine
- Details
- Category: Business

Boehringer Ingelheim and Lifebit announce partnership to capture transformational value of health data
- Details
- Category: Boehringer Ingelheim

More Pharma News ...
- Roche announces donation of essential medicines to Ukraine
- GSK announces independent Consumer Healthcare company is to be called Haleon
- BioNTech and Medigene announce global collaboration to advance T cell receptor immunotherapies against cancer
- Bayer delivers on medical innovation fueling transformation of pharma business
- BioNTech introduces first modular mRNA manufacturing facility to promote scalable vaccine production in Africa
- WHO grants prequalification of Actemra/RoActemra for patients with severe or critical COVID-19
- Lilly's bebtelovimab receives Emergency Use Authorization for the treatment of mild-to-moderate COVID-19